ロード中...
Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
Thalidomide is emerging as a potentially important therapeutic option in the treatment of metastatic prostate cancer. Although the mechanism of action of this agent remains elusive in malignancies of the prostate, recent data has indicated that thalidomide may play a role in inflammation, immunomodu...
保存先:
| 出版年: | Anticancer Agents Med Chem |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415974/ https://ncbi.nlm.nih.gov/pubmed/19719457 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|